Sponsor Dossier
Grifols
Sponsor Dossier for Grifols. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: FLEBOGAMMA
- Brand: GAMUNEX
- Brand: INTRATECT
- Brand: PROLASTIN C LIQUID
- Brand: VeraSeal
- Brand: XEMBIFY
- Device (sponsor): Immunohaematology blood grouping antisera IVDs
- Device (sponsor): Immunohaematology blood grouping antisera IVDs
- Device (sponsor): Procleix Plasmodium Assay Kit - Multiple Plasmodium species nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device (sponsor): Reagent red blood cell IVDs
- Device (sponsor): Immunohaematology sensitised cell-typing IVDs
- Device (sponsor): Procleix Parvo HAV - Hepatitis A/Parvovirus B19 virus nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device (sponsor): Multiple blood grouping and typing IVDs
- Device (sponsor): Immunohaematology-related IVDs
- Device (sponsor): Multiple blood grouping and typing IVDs
- Device (sponsor): Instrument/analyser IVDs
- Device (sponsor): Immunohaematology blood grouping antisera IVDs
- Device (sponsor): Software IVDs
- Device (sponsor): Analyser software IVDs
- Device (sponsor): Immunohaematology blood grouping antisera IVDs
- Device (sponsor): Inborn/inherited genetic disorder IVDs
- Device (sponsor): Interpretive software IVDs
- Device (sponsor): Analyser software IVDs
- Device (sponsor): Fluid transfer set, general-purpose
- Device (sponsor): Intravenous fluid container, single use
- Device (sponsor): Multiple blood grouping and typing IVDs
- Device (sponsor): Immunohaematology calibrator/control IVDs
- Device (sponsor): Reagent red blood cell IVDs
- Device (sponsor): Immunohaematology blood grouping antisera IVDs
- Device (sponsor): Immunohaematology calibrator/control IVDs
- Device (sponsor): Multiple blood grouping and typing IVDs
- Device (sponsor): Instrument/analyser IVDs
- Device (sponsor): Procleix Ultrio Elite assay - HIV1/HIV2/Hepatitis C virus/Hepatitis B virus nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device (sponsor): General laboratoryware IVDs
- Device (sponsor): Instrument/analyser IVDs
- Device (sponsor): Immunohaematology blood grouping antisera IVDs
- Device (sponsor): Immunohaematology calibrator/control IVDs
- Device (sponsor): Immunohaematology-related IVDs
- Device (sponsor): Human platelet antigen (HPA) typing IVDs
- Device (sponsor): Multiple blood grouping and typing IVDs
- Device (sponsor): Immunohaematology-related IVDs
- Device (sponsor): Immunohaematology-related IVDs
- Device (sponsor): Immunohaematology-related IVDs
- Device (sponsor): Immunohaematology sensitised cell-typing IVDs
- Device (sponsor): Reagent red blood cell IVDs
- Device (sponsor): Instrument/analyser IVDs
- Device (sponsor): Clinical chemistry-specific protein IVDs
- Device (sponsor): Clinical chemistry therapeutic drug monitoring IVDs
- Device (sponsor): General laboratoryware IVDs
- Device (sponsor): Instrument/analyser IVDs
- Device (sponsor): Instrument/analyser IVDs
About
Grifols is an Australian Private Company with ABN 35050104875, registered in Victoria. The entity is currently active.
Portfolio
Grifols has six brands on the ARTG, all of which are indexable. Five brands have Product Information on file. Notable brands include FLEBOGAMMA, GAMUNEX, INTRATECT, PROLASTIN C LIQUID, VeraSeal, and XEMBIFY. None of the portfolio holds PBS listings or PBAC outcomes, although four brands have AusPARs on record.
Therapeutic focus
— Immunology: 3 brands — Haematology: 1 brand — Neurology: 1 brand — Respiratory: 1 brand
Regulatory activity
The most recent AusPAR on record is dated 8 July 2022.